Acadia Healthcare (NASDAQ:ACHC) Shares Gap Up – Here’s What Happened

Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) gapped up before the market opened on Wednesday . The stock had previously closed at $24.42, but opened at $25.51. Acadia Healthcare shares last traded at $25.43, with a volume of 249,287 shares changing hands.

Analysts Set New Price Targets

A number of analysts have commented on ACHC shares. Zacks Research raised shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a research note on Thursday, March 5th. Guggenheim upped their price objective on shares of Acadia Healthcare from $26.00 to $31.00 and gave the company a “buy” rating in a research note on Monday, May 4th. KeyCorp reaffirmed an “overweight” rating and set a $30.00 price objective on shares of Acadia Healthcare in a research note on Wednesday, May 27th. Jefferies Financial Group raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the company from $24.50 to $30.00 in a research note on Wednesday. Finally, Barclays upped their price objective on shares of Acadia Healthcare from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Thursday, April 30th. One equities research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, Acadia Healthcare has a consensus rating of “Hold” and an average target price of $26.85.

Acadia Healthcare Stock Performance

The firm has a market capitalization of $2.32 billion, a price-to-earnings ratio of -2.06, a PEG ratio of 8.58 and a beta of 0.69. The company has a debt-to-equity ratio of 1.27, a current ratio of 1.71 and a quick ratio of 1.71. The firm’s fifty day moving average is $25.36 and its 200 day moving average is $19.65.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.28 by $0.09. The firm had revenue of $828.80 million for the quarter, compared to analyst estimates of $823.51 million. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The company’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.40 EPS. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, analysts predict that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. EverSource Wealth Advisors LLC increased its stake in Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after buying an additional 497 shares during the period. Hantz Financial Services Inc. increased its stake in Acadia Healthcare by 501.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after buying an additional 1,822 shares during the period. Wells Fargo & Company MN raised its position in Acadia Healthcare by 208.9% during the fourth quarter. Wells Fargo & Company MN now owns 2,233 shares of the company’s stock valued at $32,000 after acquiring an additional 1,510 shares in the last quarter. Bayforest Capital Ltd bought a new position in Acadia Healthcare during the fourth quarter valued at approximately $52,000. Finally, GAMMA Investing LLC raised its position in Acadia Healthcare by 124.7% during the fourth quarter. GAMMA Investing LLC now owns 4,862 shares of the company’s stock valued at $69,000 after acquiring an additional 2,698 shares in the last quarter.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.